Ignite Creation Date:
2024-05-06 @ 3:20 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04608045
Status:
COMPLETED
Last Update Posted:
2024-02-12
First Post:
2020-10-23
Brief Title:
Safety Dose Tolerance Pharmacokinetics and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors
Sponsor:
CicloMed LLC
Organization:
CicloMed LLC
Organization Data
Organization:
CicloMed LLC
Class:
INDUSTRY
Study ID:
CPX-POM-01-001EXP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CicloMed LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None